Japan COVID-19 diagnostics Market Size, Industry Trends, Share and Forecast 2020-2026

Japan COVID-19 diagnostics market will see the considerable decline of 14.7% during the forecast period. Japan has a significant share in the global COVID-19 diagnostics market owing to the growing diagnostic tests in the country coupled with the introduction of new diagnostic test for COVID-19 in the country. In Japan, earlier the detection of SARS-CoV-2 was routinely utilized by a method called nucleic acid amplification test (NAT), including PCR. While these methods were relatively accurate, it takes a couple of hours to obtain test results. On the other side, the antigen test can provide test results within 30 minutes. In addition, an antigen test does not require a special device such as PCR or other NAT method does, allowing the results to be obtained right at the testing site. Therefore, the antigen test is expected to enhance the speed and accessibility in detection of the COVID-19 in the country.

A full Report of Japan COVID-19 diagnostics Market Available at: https://www.omrglobal.com/industry-reports/japan-covid-19-diagnostics-market

Through these advantages, it is anticipated that more patients can be tested for SARS-CoV-2, providing an additional testing option to the clinical settings that are largely affected by the pandemic in country. On July 31, 2020, TOSOH Corp. received the authorization for TRCReady SARS-CoV-2, Nucleic acid test for the COVID-19 diagnosis in the country. Furthermore, on June 19, 2020, Fujirebio Inc. received the approval for the Lumipulse G SARS-CoV-2 Ag that is an antigen test for the COVID-19 by the MHLW in the country. Therefore, with approval of these rapid IVD kits, the government of Japan and MHLW projected to expand the test capacity in the country that is further estimated to propel the market growth in the country.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/japan-covid-19-diagnostics-market

Key questions addressed by the report

• What is the market growth rate during the forecast period?
• Which segment dominates the market in base year?
• Which segment will project fastest growth in the market during the forecast period?
• How COVID-19 will impact the market growth in 2020 and coming years?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Japan COVID-19 Diagnostics Market – Segmentation

By Type

• Instruments
• Reagents & Kits
• Laboratory Testing Services

By Technology Type

• PCR Test
• Antigen Test
• Serology Test
• Rapid/ PoC Test

By Sample Type

• Oropharyngeal & Nasopharyngeal Swabs
• Blood
• Urine
• Saliva
• Others (Sperm)

By End-Users

• Laboratories
• Hospitals
• Diagnostic Centers & Clinics
• Research Institutes

Company Profiles

• Eiken Chemical Co., Ltd.
• Fujirebio Inc.
• Otsuka Pharmaceutical Co., Ltd.
• Shionogi & Co., Ltd.
• Sysmex Corp.
• TOSOH Corp.
• Toyobo Co., Ltd.

For More Customized Data, Request for Report Customization https://www.omrglobal.com/report-customization/japan-covid-19-diagnostics-market

For More Information, Visit https://www.omrglobal.com

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.